The current AGEN market cap is 242.97M. The company's latest EPS is USD -0.5258 and P/E is -1.08.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 22.77M | 29.2M | 22.9M | 25.3M | 24.32M |
Operating Income | -41.65M | -56.81M | -54.75M | -54.66M | -46.34M |
Net Income | -54.28M | -71.15M | -68.31M | -69.07M | -62.25M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 38.12M | 150.05M | 88.17M | 295.67M | 98.84M |
Operating Income | -123.82M | -70.14M | -117.24M | 25.75M | -179.43M |
Net Income | -159.9M | -107.87M | -181.12M | -24.14M | -220.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 429.02M | 413.56M | 412.85M | 383.59M | 335.47M |
Total Liabilities | 440.86M | 468.46M | 465.96M | 460.35M | 450.76M |
Total Equity | -11.84M | -54.9M | -53.11M | -76.76M | -115.29M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 136.4M | 155.34M | 214.51M | 465.96M | 413.56M |
Total Liabilities | 271.07M | 359.76M | 399.1M | 418.05M | 468.46M |
Total Equity | -174.55M | -231.34M | -211.5M | 47.91M | -54.9M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -128.04M | -175.37M | -58.53M | -118.57M | -180.37M |
Investing | -27.23M | -33.61M | -11.49M | -10.97M | 576k |
Financing | 72.06M | 95.83M | 56.25M | 94.51M | 129.73M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -131.1M | -18.68M | -139.1M | 10.15M | -175.37M |
Investing | -3.59M | -4.66M | -4.44M | -43.15M | -33.61M |
Financing | 128.29M | 31.32M | 183.86M | 225.26M | 95.83M |
Market Cap | 242.97M |
Price to Earnings Ratio | -1.08 |
Price to Sales Ratio | 2.42 |
Price to Cash Ratio | 1.34 |
Price to Book Ratio | -4.35 |
Dividend Yield | - |
Shares Outstanding | 418.92M |
Average Volume (1 week) | 4.97M |
Average Volume (1 Month) | 7.95M |
52 Week Change | -63.75% |
52 Week High | 2.13 |
52 Week Low | 0.485 |
Spread (Intraday) | 0 (0.17%) |
Company Name | Agenus Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.agenusbio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.